In this episode, Chris Tew shares his journey with multiple myeloma after being diagnosed on his 69th birthday in 2021.

Note from our guest, Chris Tew:

Chris wants to make it clear that he is sharing his personal story—not offering medical advice. He is not a doctor and encourages all patients, especially those with cancer, to work closely with their hematologist/oncologist. While he did explore Ivermectin and Fenbendazole on his own, these were not part of his prescribed cancer treatment, and he does not claim they cured him. His remission is partial, not a cure, and the most significant improvements came through standard medical therapies, particularly at Huntsman Cancer Institute. Chris deeply respects his care team and is grateful for their efforts. He hopes listeners understand that alternative treatments should be approached cautiously, in consultation with professionals, and that his story is not meant to replace expert medical guidance.

Key Points:

• After years of standard treatments, Chris’s cancer marker plateaued at 0.24, while side effects began to impact his heart and vision.

• He independently began a personal protocol: Fenbendazole (220mg) and Ivermectin (36mg), five days a week with butter to aid absorption.

• His cancer marker dropped further after this addition, though he acknowledges the continued effect of previous treatments.

• Drawing on his 45-year career in medical technology, Chris describes making an “asymmetric bet”—a personal health decision he believed had more potential benefit than risk.

• He shares how cancer became a teacher, leading him to a deeper sense of patience, gratitude, and compassion.

This episode is brought to you by FierceHealth.com

My wife and I have been microdosing Semaglutide through Fierce as part of our ​Cancer Protocol​ for the past 6 months.

Use code PODCAST for 10% off.

This interview is part of the reason why we are building CancerCrew.com, a private community for those navigating cancer—whether you’re the one diagnosed or supporting your loved one. Click to join the waitlist now.